Clinical Trials Browser

OTHER × Cardiovascular Diseases × ibrutinib × Clear all

NCT06561243 2024-08-21

Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies

Active not recruiting

15,000 enrolled

Cardiovascular Diseases